Effectiveness of Three Oral Devices as Mouthguard in Electroconvulsive Therapy. Randomized Crossover Clinical Trial.

NCT ID: NCT02678715

Last Updated: 2022-05-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

4 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-02-29

Study Completion Date

2022-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This observer-blind crossover intervention study aims to determine the most effective type of device as oral mouthguard in modified-Electroconvulsive Therapy (m-ECT) comparing three types of devices: standard, prefabricated and manufactured in the dental laboratory.

Patients from the ECT Unit of Psychiatric Department of the University Hospital of Bellvitge will use the three devices at a random sequence during the twelve treatment sessions, so each device (A, B, C) will be used for two weeks, that is, for four consecutive sessions.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Treatment with electroconvulsive therapy will involve the application of 12 m-ECT sessions at the rate of two sessions for six weeks according to the protocol established in the ECT Unit of the Department of Psychiatry at the University Hospital of Bellvitge.

Two devices, SB and CA, will be prepared for each patient and placed in mouth before anesthesia by one operator. This operator will assign a randomized sequence of use of the three devices (SB, CA or SM). Device SM will be the sole protector that will be placed after the anesthesia by nurse.

The outcome assessor will the scans pre- and post-session m-ECT and collect data, accede the surgery room before the session with the patient conscious and perform the exploration. This outcome assessor will leave the operating room during the procedure for the application of m-ECT an come back an hour later for the post-examination session.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Temporomandibular Joint Dysfunction Syndrome Tooth Injuries Dental Occlusion, Traumatic

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Sequence SB-CA-SM

Solubrux®+ Customized Appliance + Somatics®

Group Type EXPERIMENTAL

Solubrux®

Intervention Type DEVICE

prefabricated device adaptable by temperature

Customized Appliance

Intervention Type DEVICE

customized device fabricated in the dental laboratory

Somatics®

Intervention Type DEVICE

standard device

Sequence SB-SM-CA

Solubrux®+Somatics®+Customized Appliance

Group Type EXPERIMENTAL

Solubrux®

Intervention Type DEVICE

prefabricated device adaptable by temperature

Customized Appliance

Intervention Type DEVICE

customized device fabricated in the dental laboratory

Somatics®

Intervention Type DEVICE

standard device

Sequence CA-SB-SM

Customized Appliance+Solubrux®+Somatics®

Group Type EXPERIMENTAL

Solubrux®

Intervention Type DEVICE

prefabricated device adaptable by temperature

Customized Appliance

Intervention Type DEVICE

customized device fabricated in the dental laboratory

Somatics®

Intervention Type DEVICE

standard device

Sequence CA-SM-SB

Customized Appliance+Somatics®+Solubrux®

Group Type EXPERIMENTAL

Solubrux®

Intervention Type DEVICE

prefabricated device adaptable by temperature

Customized Appliance

Intervention Type DEVICE

customized device fabricated in the dental laboratory

Somatics®

Intervention Type DEVICE

standard device

Sequence SM-SB-CA

Somatics®+Solubrux®+Customized Appliance

Group Type EXPERIMENTAL

Solubrux®

Intervention Type DEVICE

prefabricated device adaptable by temperature

Customized Appliance

Intervention Type DEVICE

customized device fabricated in the dental laboratory

Somatics®

Intervention Type DEVICE

standard device

Sequence SM-CA-SB

Somatics®+ Customized Appliance+Solubrux®

Group Type EXPERIMENTAL

Solubrux®

Intervention Type DEVICE

prefabricated device adaptable by temperature

Customized Appliance

Intervention Type DEVICE

customized device fabricated in the dental laboratory

Somatics®

Intervention Type DEVICE

standard device

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Solubrux®

prefabricated device adaptable by temperature

Intervention Type DEVICE

Customized Appliance

customized device fabricated in the dental laboratory

Intervention Type DEVICE

Somatics®

standard device

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients should have an intellectual level that allows a proper communication and must agree to cooperate in all tests and exams required by the study protocol.
* Obtaining written informed consent for participating in the project (model consent form)
* The patient must have enough teeth in the upper arch or being a carrier of a stable removable prosthesis.

Exclusion Criteria

* Being in a maintenance ECT program.
* Receiving ECT during the six months prior to the index episode.
* Pregnancy and lactation.
Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Eva Willaert Jiménez-Pajarero

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Eva Willaert Jiménez-Pajarero

DDS, PhD

Responsibility Role SPONSOR_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hospital Universitari de Bellvitge

L'Hospitalet de Llobregat, Barcelona, Spain

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Spain

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

AC089/15

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Bruxism and Diadinamic Current
NCT07241728 RECRUITING NA